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Signal regulatory protein alpha (SIRPα/CD172a) is a conserved transmembrane protein
thought to play an inhibitory role in immune function by binding the ubiquitous ligand
CD47. SIRPα expression has been used to identify dendritic cell subsets across species
and here we examined its expression and function on intestinal DCs in mice. Normal
mucosa contains four subsets of DCs based on their expression of CD103 and CD11b
and three of these express SIRPα. However, loss of SIRPα signaling in mice leads to a
selective reduction in the CD103+CD11b+ subset of DCs in the small intestine, colon, and
amongmigratory DCs in themesenteric lymph node. In parallel, these mice have reduced
numbers of TH17 cells in steady-state intestinal mucosa, and a defective TH17 response
to Citrobacter infection. Identical results were obtained in CD47KO mice. DC precursors
from SIRPαmutant mice had an enhanced ability to generate CD103+CD11b+ DCs in vivo,
but CD103+CD11b+ DCs from mutant mice were more prone to die by apoptosis. These
data show a previously unappreciated and crucial role for SIRPα in the homeostasis of
CD103+CD11b+ DCs in the intestine, as well as providing further evidence that this subset
of DCs is critical for the development of mucosal TH17 responses.
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 Additional supporting information may be found in the online version of this article at thepublisher’s web-site
Introduction
The intestinal immune system is exposed to a wide variety of
foreign antigens including dietary constituents, commensal micro-
organisms and pathogens. DCs, the professional antigen present-
ing cells in the gut, must ensure that the correct kind of T cell
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is primed so that tolerance or protective immunity is induced
appropriately [1, 2]. We and others have shown recently that four
distinct subsets of genuine DCs can be identified in the intestine
on the basis of CD103 and CD11b expression [2–6], but the con-
tribution of each subset to the different kinds of intestinal immune
responses remains largely unknown.
Signal regulatory protein alpha (SIRPα/CD172a) expression is
found on the majority of myeloid cells. However, it is expressed
differentially by subsets of DCs, being present on CD11b+ DCs
in mice, but not on the DCs with cross-presenting activity
C© 2014 The Authors. European Journal of Immunology published byWILEY-VCH Verlag GmbH& Co. KGaA
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characterized by expression of CD8α and CD103 [6–10]. SIRPα
is a transmembrane receptor whose cytoplasmic domain contains
a tyrosine-based inhibition motif that binds and activates SHP1
and SHP2 phosphatases [9, 11, 12]. The ligand for SIRPα is the
ubiquitously expressed CD47 and this interaction is gener-
ally believed to have inhibitory effects on immune function,
having been implicated in the pathogenesis of a number of
models of autoimmunity including experimental autoimmune
encephalomyelitis, contact hypersensitivity, and collagen-induced
arthritis [13–16].
The SIRPα-CD47 axis has also been implicated in regulating
immunity in the gut, although the exact effects and basis for
this regulation remain unclear. Thus although CD47KO mice have
reduced susceptibility to experimental colitis [17] and decreased
intestinal IgA production, they show normal tolerance when
administered protein antigens orally [18].
SIRPα mutant mice [19], which have a truncated cytoplas-
mic domain of the protein and hence cannot signal intracellularly,
have a reduction in the proportion of flagellin inducible IL-17- and
IFN-γ-producing T cells in the intestinal lamina propria (LP) [20].
Although some of these effects have been linked to abnormalities
in the SIRPα+ (CD11b+) subset of “DCs” [18, 20], their interpre-
tation is clouded by the fact that these cells were identified only
on the basis of expression of CD11c and MHCII. Furthermore it
was assumed that CD11b and CD103 defined mutually exclusive
subsets of intestinal DCs as they do in other tissues [21]. Recently,
we and others have shown that most CD11b+CD11c+MHCII+ cells
in the intestinal mucosa are resident macrophages rather than the
migratory DCs that are needed to drive na¨ıve T-cell priming. In
addition, a substantial population of intestinal DCs express both
CD103 and CD11b [4, 22–24]. Here, we have exploited more rig-
orous identification strategies to reexamine how the SIRPα-CD47
axis regulates intestinal immunity. We show that although SIRPα
is expressed by macrophages and three distinct populations of DCs
in the gut; the loss of CD47 or SIRPα signaling leads to a selective
decrease in CD103+CD11b+ DCs, together with a decrease in the
generation of intestinal TH17 cells. The loss of CD103+CD11b+
DCs in SIRPα mutant mice appears to reflect enhanced suscep-
tibility of these cells to die by apoptosis rather than defective
generation from DC progenitors.
Results
Loss of SIRPα-CD47 signaling results in a specific
reduction in intestinal CD103+CD11b+ DCs
We first investigated exactly which small intestine lamina pro-
pria (SI LP) DC subsets expressed SIRPα, using our recently
established gating strategy in which bona fide DCs among
mucosal mononuclear phagocytes (MPs) are identified as CD11c+
MHCII+CD64−F4/80− [3, 4, 22, 30]. On this basis, three SIRPα-
expressing subsets of DCs could be observed: CD103+CD11b+,
CD103−CD11b+, and CD103−CD11b− (Fig. 1A). The SIRPα− DC
population contained both CD103+CD11b− and CD103−CD11b−
subsets, with all CD103+CD11b− DCs failing to express SIRPα,
whereas the CD103−CD11b− population was heterogeneous for
SIRPα expression. SIRPα expression was mutually exclusive to
that of CD8α, which was found on all CD103+CD11b− DCs and
on some CD103−CD11b− DCs, but not on the CD11b+ subsets
(Fig. 1A). As expected [4, 22], all CD11c+MHCII+CD64+F4/80+
resident macrophages also expressed SIRPα (Fig. 1A). Similar pat-
terns of staining were observed among the mononuclear phago-
cytes in the colonic LP (Fig. 1B) and among migratory DC
(CD11c+MHCIIhi) in the mesenteric lymph nodes (Fig. 1C).
Next, we investigated whether SIRPα played a functional role
in intestinal DCs, using mice with a truncated cytoplasmic domain
of SIRPα (SIRPα mt) that cannot signal intracellularly [19]. These
mice had a selective reduction in the proportion and absolute num-
ber of CD103+CD11b+ DCs in the SI (Fig. 2A), colon (Support-
ing Information Fig. 1), and among migratory CD11c+MHCIIhi
DCs in the MLNs (Fig. 2B). Although the absolute numbers of
all migratory DC subsets were reduced in the MLNs of SIRPα
mt mice, this reflected a global reduction in cellularity and only
the CD103+CD11b+ DCs showed a proportional defect in mutant
MLNs (Fig. 2C). The other SIRPα expressing intestinal MPs includ-
ing macrophages, were unaffected by the loss of SIRPα signaling
in either the SI or colon (Fig. 2D and Supporting Information
Fig. 1C).
CD47KO mice phenocopy the DC defect in SIRPα mt
mice
CD47KO mice had a selective and equivalent reduction in
CD103+CD11b+ DCs in both the SI LP and migratory compart-
ment of the MLNs (Fig. 3A and B), as well as normal proportions
and numbers of mucosal macrophages (Fig. 3C).
Reduction in CD103+CD11b+ DCs correlates with a
selective defect in intestinal TH17 cells
As CD103+CD11b+ DCs have recently been implicated in the
homeostasis of mucosal TH17 cells [5, 6, 13, 26–29], we next
examined the CD4+ T-cell compartment in the small intestinal LP
of steady-state SIRPα mt and CD47KO animals. Both SIRPα mt
and CD47KO mice showed an approximately 50% reduction in
IL-17-producing TH17 cells compared with WT LP, whereas the
numbers of FoxP3+ Treg and IFN-γ+ TH1 cells were unaffected
(Fig. 4A and B, and Supporting Information Fig. 2A). In addition,
SI LP CD4+ T cells FACS-purified from SIRPα mt mice had a trend
toward reduced il22 mRNA expression (Supporting Information
Fig. 2B). During infection by the intestinal pathogen Citrobacter
rodentium, SIRPα mt mice also showed defective induction of
TH17 cells in the MLNs, as well as a trend toward reduced
proportions of CD4+ T cells producing IL-22 in the colonic LP,
where there was a 40% reduction compared with the levels in
WT colon (Fig. 4C and D, and Supporting Information Fig. 2C).
These changes in T-cell differentiation were associated with
C© 2014 The Authors. European Journal of Immunology published by
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Figure 1. SIRPα expression on intestinal mononuclear phagocytes. (A) Mononuclear phagocytes were identified among live single CD45+ cells from
enzymatically digested small intestinal lamina propria as CD11c+MHCII+. Contaminating B cells were excluded on the basis of B220 expression and
DCs and macrophages were identified as CD64− or CD64+, respectively. Top panels: Expression of CD103 and CD11b by CD11c+SIRPα− (black) and
CD11c+SIRPα+ (red) DCs. Bottom panels: Expression of SIRPα and CD8α by DC subsets and CD64+ macrophages (isotype controls shown in gray). (B)
Expression of SIRPα by mononuclear phagocytes in the colonic LP gated as described in (A). (C) Expression of SIRPα by CD103/CD11b-based subsets
of migratory (CD11c+MHCIIhi) DCs in the mesenteric lymph node. (A–C) Plots are from one experiment representative of at least six independent
experiments, with n = 3–4 mice/experiment.
delayed clearance of the pathogen (Fig. 4E). Importantly, these
differences were not due to impaired IL-22 production by
type 3 innate lymphoid cells (ILC3s) (Supporting Information
Fig. 2D).
As we have recently shown that CD103−CD11b+ DCs from
the intestine are the main inducers of TH17 differentiation in
vitro [3, 30], we assessed whether a functional defect in this
population could account for the impaired TH17 priming in SIRPα
mt mice, despite the normal numbers of this subset. However,
CD103−CD11b+ DCs from the SI LP of SIRPα mt mice were
equally capable of inducing TH17 responses as their WT coun-
terparts following ex vivo coculture with na¨ıve CD4+ OTII T cells
C© 2014 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA Weinheim
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Figure 2. SIRPα signaling controls the homeostasis of CD103+CD11b+ DCs in vivo. (A) Proportions and absolute numbers of CD103/CD11b-based
subsets among live CD45+CD11c+MHCII+CD64−B220− DCs from small intestinal LP of SIRPα mutant (mt) (filled circles) and WT (empty circles)
mice. (B) Proportions and absolute numbers of CD103/CD11b-based subsets among CD11c+MHCIIhi migratory DCs in the MLNs of SIRPα mt and
WT mice. (C) Frequency of live total CD45+ cells in the MLNs of SIRPα mt and WT mice. (D) Proportions and numbers of CD64+ macrophages
among live CD45+CD11c+MHCII+ cells in small intestinal LP of SIRPα mt and WT mice. Data are from one experiment representative of at least
five independent experiments, with n = 3/4 per experiment. *p < 0.05, **p < 0.01, ***p < 0.005; Student’s t-test.
(Fig. 4F). The reduced TH17 cell generation in vivo was also not
due to an intrinsic defect in SIRPα mt T cells, as na¨ıve CD4+
T cells from SIRPα mt MLNs could be polarized in vitro to express
RORγt and IL17a at levels equivalent to WT MLN CD4+ T cells
(Fig. 4G).
In contrast to this defect in TH17 cell generation, regulatory
T cell dependent mechanisms appeared to be normal in the
absence of SIRPα signaling. Thus there were normal numbers
and proportions of FoxP3+ Treg cells in the SIRPα mt SI and
colon (Fig. 4A and B, and Supporting Information Fig. 2A and
E), although a slight reduction was observed in the MLNs (Sup-
porting Information Fig. 2F). In addition these mice developed
tolerance of systemic delayed type hypersensitivity responses nor-
mally when fed OVA before parenteral challenge with antigen in
CFA (Supporting Information Fig. 2G).
Development of CD103+CD11b+ DC from precursors is
enhanced by the loss of SIRPα-CD47 signaling
As CD103+CD11b+ intestinal DCs are the progeny of
DC-committed progenitors that express SIRPα [23, 25, 30], we
explored whether defective SIRPα signaling might affect the
generation of these DCs. Normal numbers of pre-DCs were present
in the BM and blood of SIRPα mt mice [31, 32] (Fig. 5A). To
study their ability to generate intestinal DCs in vivo, CD45.1+ WT
C© 2014 The Authors. European Journal of Immunology published by
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Figure 3. CD47KO mice phenocopy the intestinal DC defect in SIRPα
mt mice. (A) Proportions and absolute numbers of CD103/CD11b-based
subsets among live CD45+CD11c+MHCII+CD64−B220− DCs from small
intestinal LP of CD47KO (filled circles) and WT (empty circles) mice.
(B) Proportions and absolute numbers of CD103/CD11b-based subsets
among CD11c+MHCIIhi migratory DCs in the MLNs of CD47KO and WT
mice. (C) Proportions and numbers of CD64+ macrophages among live
CD45+CD11c+MHCII+ cells in small intestinal LP of SIRPα mt and WT
mice. Data are from one experiment representative of at least three
independent experiments, with n = 3/4 per experiment. *p < 0.05,
**p < 0.01, ***p < 0.005; Student’s t-test.
and CD45.2+ SIRPα mt pre-DCs were transferred in a 50:50 ratio
into CD45.1+/CD45.2+ WT recipient mice (Fig. 5B). The mature
progeny were then identified in the SI LP 5 days after transfer
(Fig. 5C), a time we had found optimal for the development of
DCs in the gut in this system (data not shown). Unexpectedly,
SIRPα mt pre-DCs appeared to be more effective at generating
CD103+CD11b+ DCs in LP than their WT counterparts, as well
as being somewhat better at generating SIRPα−CD103+CD11b−
DCs (Fig. 5D). SIRPα mt and WT pre-DCs had equal abilities to
generate the two CD103− DC populations, both of which express
SIRPα (Fig. 5D).
Increased apoptosis of CD103+CD11b+ DCs in the
absence of a functional SIRPα signal
The selective advantage of SIRPα mt pre-DCs in generating
CD103+CD11b+ DCs, despite the marked deficiency in this sub-
set seen in SIRPα mice, suggested that these DCs might be com-
promised by the lack of SIRPα signaling later in their life. To
explore this, we compared the apoptosis of intestinal DC subsets
in SIRPα mt and WT mice. Annexin V staining showed that migra-
tory CD103+CD11b+ DCs were more prone to apoptosis in SIRPα
than in WT MLNs. In contrast, no differences in Annexin V stain-
ing were noted among the other DC populations (Fig. 6). Thus
the SIRPα/CD47 axis appears to be important for promoting the
survival of intestinal CD103+CD11b+ DCs.
Discussion
Here, we have exploited recent advances in characterizing intesti-
nal DCs and their subsets to explore the significance of SIRPα
expression on these cells. We demonstrate that three of the
four subsets of bona fide DCs, that we and others have iden-
tified in the mouse intestine [3–5, 30] express SIRPα, these
being CD103+CD11b+, CD103−CD11b+, and CD103−CD11b−.
The remaining CD103+CD11b− DCs are uniformly SIRPα− and
comprise the CD8α+DNGR-1+XCR1+ population responsible for
cross-presentation [33]. Some CD103−CD11b− DCs also fail to
express SIRPα, consistent with previous findings that this subset
is phenotypically heterogeneous and its functions remain to be
elucidated [3].
Despite its widespread expression, loss of SIRPα signaling in
SIRPα mt mice caused a selective reduction in CD103+CD11b+
DCs in the LP of the entire intestinal tract and among migratory
DCs in MLNs. The other subsets of SIRPα+ DC were unaffected, as
were CD64+ macrophages, which are uniformly SIRPα+. Identical
results were obtained in mice lacking the ligand for SIRPα, CD47,
extending a previous study that found reduced CD103+CD11b+ LP
DCs in CD47KO mice, but in which the other DC populations were
not examined [18]. Other groups also found reduced numbers of
CD11b+ “DCs” in the LP of SIRPα mt and CD47KO mice, but these
were reported to lack CD103 and the cells analyzed were total
CD11c+CD11b+ MPs [17, 20]. As we show here, this population is
highly heterogeneous, containing macrophages, CD103−CD11b+
DCs and CD103+CD11b+ DCs, which can only be distinguished by
multiparameter analysis. As CD103+CD11b+ DCs are a relatively
minor part of this overall population, they could easily have been
overlooked in earlier studies.
C© 2014 The Authors. European Journal of Immunology published by
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Figure 4. Defects in CD103+CD11b+ intestinal DCs correlate with reduced TH17 cells in LP. (A, B) Proportions and absolute numbers of cells
staining intracellularly for IL-17a, FoxP3, and IFN-γ among total live CD4+ T cells in the small intestinal LP of SIRPα mt mice (A) and CD47KO
mice (B) (filled circles), together with WT controls (empty circles). (A and B) Data are pooled from 2–3 independent experiments, with n = 4 per
experiment. (C) Mice were infected orally with 1 × 109 CFU of C. rodentium and the numbers of IL-17a producing CD4+ T cells in MLNs assessed
on day 8 of infection by intracellular cytokine staining. Results show proportion of TH17 cells as a percentage of total CD4+ T cells in the MLN
of SIRPα mt and WT mice. Data are from one experiment representative of two independent experiments, with n = 3–6 mice per experiment.
(D) IL-22 producing CD4+ T cells in the colonic LP of SIRPα mt (filled circles) and WT (empty circles) mice 8 days after infection with C. rodentium
as assessed by intracellular cytokine staining. Results show the proportions of IL-22 producing cells as a percentage of total CD4+ T cells. Data
are from a single experiment with n = 2–8 mice/group. NI (x) represents noninfected WT controls. (E) Course of infection with C. rodentium in
WT and SIRPα mt mice. The data are shown as mean ± SD (CFU × 103/g feces) from ten mice/group and are from one experiment representative
of two experiments. (F) CD103−CD11b+ DCs (3 × 104) were FACS-purified from the SI LP of WT and SIRPα mt mice, pulsed with 2 mg/mL OVA
and cocultured with FACS-purified naı¨ve (CD62L+CD25−) CD4+ OVA-specific OTII transgenic T cells for 4 days before being assessed for IL-17a
production by intracellular cytokine staining. Data are pooled from three independent experiments. (G) FACS-purified naive CD62L+CD25−CD4+
T cells from the MLN of SIRPα mt or WT mice were cultured for 4 days on plates coated with anti-CD3 and anti-CD28, together with anti-IFN-γ,
anti-IL-4, anti-IL-2, IL-6, IL-23, IL-1β, and TGF-β. RORγt and IL-17a expression were then assessed by intracellular staining. Data are shown as
means ± SD pooled from two independent experiments, with n = 6-7 per group. *p < 0.05, **p < 0.01; Student’s t-test
As has been reported previously [13, 34–36], the reduction in
CD103+CD11b+ DCs which we observed in the intestine of SIRPα
mt and CD47KO mice was accompanied by a defect in CD11b
expressing DCs in other tissues such as the spleen. However, the
phenotypically identical CD103−CD11b+ DC subset in the intes-
tine was not affected by the SIRPα mutation. CD103 expression
on CD11b+ (SIRPα+) DCs is unique to the intestine and appears
to reflect tissue specific "conditioning" by that environment [2].
Similarly concordant defects in CD11b+ splenic DCs and in the
CD103+CD11b+ subset in LP are also present in mice with IRF4
and Notch2 deficiency targeted to CD11c+ cells, but the effects
on CD103−CD11b+ DCs in the intestine of these mice remain to
be investigated [5, 6, 26, 37]. Together, our results could suggest
a model in which mucosal CD103−CD11b+ DCs are less mature
than either the CD103+CD11b+ DCs in intestine or CD11b+ DC in
the spleen, and that SIRPα signaling is essential for their full dif-
ferentiation. We are currently examining this idea in more detail.
The loss of CD103+CD11b+ intestinal DCs in SIRPα mt and
CD47KO mice was accompanied by a selective reduction in
IL-17/IL-22 producing CD4+ T cells in the steady-state intestinal
LP, whereas TH1 cells and FoxP3+ Treg cells were unaffected.
Similar defects in TH17/22 generation were found during
C© 2014 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA Weinheim
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Figure 5. Loss of functional SIRPα signal confers a selective advantage in the generation of CD103+CD11b+ DCs from pre-DCs. (A) Proportions
of Lin−CD11cintSIRPαintCD135+ pre-DCs in the BM and blood of WT and SIRPα mt mice. Data are shown as% of total cells ± 1 SD and are from
one experiment representative of 2–5 independent experiments with n = 3–4 per group per experiment. (B) Lin−CD11cintSIRPαintCD135+ pre-DCs
were FACS sorted from the BM of CD45.1+ WT and CD45.2+ SIRPα mt mice ten days after subcutaneous injection of 2 × 106 Flt3L secreting B16
cells, labeled with CellTrace violet dye, mixed in a 50:50 ratio and 7 × 105 cells were transferred i.v. into resting CD45.1+/CD45.2+ WT recipients.
(C) Five days later, CellTrace+ total donor cells were identified in the SI LP of recipient mice and examined for CD103 and CD11b expression.
(D) Donor-derived DCs were then examined for CD45.1 and CD45.2 expression to assess their origin fromWT versus SIRPα mt precursors. The data
are shown as the mean ± SD (n = 4) and are pooled from two independent experiments. *p < 0.05, **p < 0.01, Student’s t-test.
infection with C. rodentium in SIRPα mt mice, which also showed
delayed clearance of the organism. Protective immunity in this
infection requires IL-22 and IL-17, produced by different cells
in two distinct phases. Early in infection, these cytokines are
derived from ILC3s, whereas CD4+ T cells are needed for the
later stage in which the pathogen is cleared [38]. The role of
CD103+CD11b+ DCs in this infection has been controversial,
as although one report suggested that they were required to
drive the early IL-22 production by ILC3s [37], others found
that CD103+CD11b+ DCs were not required for clearance of
the organism [27]. Here, we found that the delayed clearance
in SIRPα mt mice only became apparent at the later stages of
infection and this correlated with fewer TH17 and TH22 cells in
the MLNs and colonic LP. In contrast, we could not find any defect
in IL-22 production by ILC3 in SIRPα mt mice. For these reasons
we conclude that the enhanced susceptibility of these mice to
C. rodentium infection reflects defective priming of adaptive effec-
tor T cells by CD103+CD11b+ DCs rather than an effect on ILC3s.
Our findings of reduced generation of intestinal TH17 cells
in SIRPα mt mice are consistent with other disease models in
these mice, including EAE, contact hypersensitivity and collagen-
induced arthritis [13, 14, 16]. Recent studies in other mouse
models have also confirmed a specific link between reduced num-
bers of CD103+CD11b+ DCs and fewer TH17 cells in the gut, per-
haps reflecting reduced production of polarizing cytokines such as
IL-6 or IL-23 [5, 6, 26, 27, 37]. However, the exact mechanisms
underlying the connection remain to be elucidated and it should
be noted that our recent studies show that CD103−CD11b+ DCs
are the most effective inducers of TH17 cell differentiation when
DC subsets from intestinal LP or lymph are assessed using na¨ıve
antigen-specific CD4+ T cells in vitro [3, 30]. The explanation for
these apparently discordant results is unknown, but could indi-
cate that the CD103+ and CD103− subsets of CD11b+ DCs may
represent different stages in the same developmental pathway, or
they may need to interact together in vivo to generate TH17 cells.
Alternatively the subsets may play separate roles in the induc-
tion and subsequent maintenance of TH17 cells in vivo. This latter
idea could be consistent with work suggesting that the effects
of CD103+CD11b+ DCs on the homeostasis of TH17 cells in the
intestine may not require presentation of cognate antigen [27].
Furthermore, recent studies show that the induction of TH17 cells
in the intestine by Segmented Filamentous Bacteria involves two
processes, one of which requires uptake via secondary lymphoid
organs and presentation of specific antigen by DCs; a further pop-
ulation of segmented filamentous bacteria-dependent TH17 cells
is independent of these events [39, 40]. More work is needed to
define better the link between different DC subsets and TH17 cell
homeostasis in the intestine.
The loss of SIRPα signaling did not affect the numbers of
FoxP3+ Treg in the steady-state LP, and SIRPα mt mice devel-
oped systemic tolerance normally after feeding protein, a phe-
nomenon that is dependent on Treg cells [1]. These results are
consistent with previous studies showing normal oral tolerance in
CD47KO mice [18] and with other recent work showing normal
numbers of FoxP3+ Treg cells when CD103+CD11b+ DCs are lack-
ing [2, 27]. Thus original assumptions that intestinal CD103+ DCs
were intrinsically tolerogenic need to be reassessed in the light of
newer insights into their heterogeneity and function [41–44].
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Figure 6. Increased apoptosis of CD103+CD11b+ DCs in the absence of
a functional SIRPα signal. DC subsets among CD11c+MHCIIhi migratory
DCs in whole MLNs isolates from WT and SIRPα mt mice were stained
for Annexin V and 7-AAD. (A) Representative plots showing Annexin V
and 7-AAD staining by CD103/CD11b DC subsets among CD11c+MHCIIhi
migratory DCs. Numbers represent proportions of apoptotic (Annexin
V+ 7-AAD−) cells in each subset. (B) Representative plot showing
Annexin V and 7-AAD staining in fluorescence minus one controls
used to set gates among total migratory (CD11c+ MHCIIhi) DCs. (A and
B) Plots are from one representative of four experiments, with 3–4
mice/group/experiment. (C) Proportions of apoptotic (Annexin V+
7-AAD−) cells as a percentage of each DC subset in WT and SIRPα mt
MLNs. Data are pooled from four independent experiments, with
n = 3–4 mice/group/experiment. **p < 0.01; Student’s t-test.
Previous studies have suggested that defective numbers of
CD11b+ DCs in secondary lymphoid organs of SIRPα mt or
CD47KO mice might reflect reduced migration via afferent lym-
phatics [35, 36, 45]. However, this is unlikely to account for our
findings, as we observed a similar defect CD103+CD11b+ DCs
in both the mucosa and draining MLNs. Although the commit-
ted precursors of DCs express SIRPα [31], their numbers were not
altered in the BM or blood of SIRPα mtmice. Indeed we found that
these pre-DCs actually appeared to be more efficient at generating
CD103+CD11b+ DCs in the mucosa compared with WT pre-DCs.
This indication that SIRPα may normally function as a checkpoint
in the development of a specific subset of intestinal DCs contra-
dicts previous findings in the spleen where pre-DCs from SIRPα mt
mice were found to have a reduced ability to generate CD11b+ DC
compared with WT pre-DCs [34]. This could reflect an intrinsic
difference in ontogeny between CD11b+ DCs in systemic lymphoid
tissues and intestinal CD103+CD11b+ DCs; indeed the latter DCs
are not found elsewhere in the body. An alternative explanation
may be that we analyzed donor cells 5 days after transfer, whereas
Saito et al did not examine the fate of pre-DCs in the spleen until
8 days after transfer [34]. Interestingly, these groups also found
that the progeny of SIRPα mt pre-DCs had an unusually short
half-life in vivo and indeed, we did not find enhanced generation
of CD103+CD11b+ by SIRPα mt pre-DCs when the intestine was
examined 7 days after transfer. Thus, this earlier study may have
missed the accelerated development that we observed.
The idea that CD103+CD11b+ DCs in SIRPα mt mice are com-
promised in their survival was supported by their increased sus-
ceptibility to apoptosis in the MLNs. Although the lengthy enzy-
matic digestion needed to isolate LP DCs precluded analysis of
apoptosis in these cells, all CD103+CD11b+ DCs in the MLNs are
within the “migratory” gate, indicating they have come from the
mucosa [3, 46]. Thus reduced survival is likely to be an intrinsic
property of this subset that resides in LP as part of its life cycle.
Whether these cells actually die in the mucosa itself, or their sur-
vival defect only becomes apparent once they have migrated to
the MLNs remains to be determined.
Overall our results demonstrate a previously unappreciated
role for SIRPα in the homeostasis of CD103+CD11b+ DCs in
the intestine. We propose that this subset of DCs develops more
rapidly in the absence of SIRPα and is then more susceptible to
activation and subsequent death. SIRPα may therefore normally
act as a brake on these processes via its ability to inhibit signal-
ing pathways by binding SHP1 phosphatase [12]. However, an
alternative explanation could come from the finding that SIRPα
can also promote survival pathways in other cell types via SHP2-
mediated induction of MAPK, PI3 kinase, and NF-κB [47]. Loss of
SIRPα signaling could therefore compromise DC survival via this
mechanism. As our own and other recent work indicates that
SIRPα expressing DCs are also present in substantial numbers in
human intestine [6, 10, 30] elucidating the mechanisms of SIRPα
mediated control of their development and functions could have
important clinical implications.
Materials and methods
Mice
Wild-type C57BL/6 (B6) mice were purchased from Harlan Olac
(Bicester, UK). SIRPα mt mice [19] were obtained from Dr. PA
Oldenberg (Umea University, Sweden) with kind permission from
T.Matozaki (University of Tokyo, Japan). CD47KOmice [48] were
purchased from Jackson Laboratories (Maine, USA). All strains
were backcrossed for at least nine generations on to the B6 back-
ground and were maintained under specific pathogen free condi-
tions at the University of Glasgow animal facilities, before being
used between 6 and 12 weeks of age. Animal experiments were
performed in accordance with UK Home Office guidelines.
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Murine cell isolation
Lamina propria cells were obtained from murine intestines by
enzymatic digestion as previously described [3, 49]. Cells were
isolated frommesenteric lymph nodes by enzymatic digestion with
1 mg/mL collagenase D (Roche) in calcium magnesium free
Hank’s balanced salt solution (Gibco, Invitrogen) for 45 minutes.
After isolation, cells were passed through a 100 μm and then a
40 μm filter before use (Corning).
Flow cytometric analysis and sorting of cells
Cells were stained at 4°C in the dark, as previously described
in [49]. For intracellular cytokine staining, whole LP digests were
incubated for 4.5 hwith 1×Cell stimulation cocktail (eBioscience)
before fixation and permeabilisation. In all analyses, following
doublet exclusion, live cells were identified using 7-AAD (Biole-
gend) or fixable viability dye (eBioscience). Data were acquired
on an LSR II or FACSAria I (BD Biosciences) and analyzed using
FlowJo software (Tree Star Inc).
T-cell polarization in vitro
Ultra low adherence 24-well plates were coated with 1.5 μg/mL
anti-CD3 and 1.5 μg/mL anti-CD28 (BD Biosciences) in calcium
magnesium free PBS for 6 h at 4°C. After washing the plates,
8 × 105 FACS-purified na¨ıve CD4+CD62Lhi CD25− T cells from
MLNs were added in 1 mL complete RPMI supplemented with
10 μg/mL anti-IFN-γ, 10 μg/mL anti-IL-4, 10 μg/mL anti-IL-2,
20 ng/mL IL-6, 20 ng/mL IL-23, 20 ng/mL IL-1β (all BD
Biosciences), and 2.5 ng/mL recombinant human TGF-β (Pepro-
tech). Cells were incubated at 37°C with 5% CO2 for 4 days and
supplemented with 500 μL complete RPMI on day 3. On day
4 cells were harvested and cultured with cell stimulation cocktail
for 4.5 h at 37°C with 5% CO2. The cells were then harvested and
stained for intracellular IL-17a and RORγt.
DC: T cell cocultures
CD103−CD11b+ DCs (3 × 104) were FACS-purified from the
SI LP and pulsed with 2 mg/mL OVA for 2 h. Cells were then
washed extensively and cocultured for 4 days with 1 × 105 CFSE-
labeled na¨ıve CD4+ OVA-specific Transgenic OTII T cells (sorted
as CD62Lhi, CD25−). Following coculture, T cells were restimu-
lated for 4.5 h with 1× cell stimulation cocktail (eBiosciences)
and IL-17a production was assessed as described above.
Adoptive transfer of pre-DCs
To expand pre-DCs, CD45.1+ WT or CD45.2+ SIRPα mt mice were
injected with 2 × 106 flt3L secreting B16 tumor cells subcuta-
neously (a kind gift from Dr. Oliver Pabst, Hannover, Germany)
and 10–14 days later, BM was isolated and RBCs lysed (Stem Cell
Technologies). Cells were labeled with eFluor450 CellTrace Vio-
let proliferation dye (eBioscience) and pre-DCs were identified as
Lin− (CD3, CD19, B220, CD49b, MHCII, and CD11b), CD11cint
SIRPαintCD135+ cells as previously reported [30]. A total of
3.5 × 105 FACS sorted pre-DCs were injected into unmanipu-
lated CD45.1+/CD45.2+ recipients in a 50:50 mixture. Five days
later recipient mice were examined for donor cells.
Assessment of apoptosis
Apoptosis was assessed onMLN cells by staining for Annexin V (BD
Biosciences) in conjunction with 7-AAD according to the manu-
facturer’s guidelines and analyzed by flow cytometry.
C. rodentium infection
C. rodentium (ATCC 51459) was cultured with aeration in DMEM
to log phase (OD650 = 1.0) before concentration by centrifugation.
WT and SIRPα mt mice were inoculated with 1 × 109 C. rodentium
organisms by oral gavage and the level of infection was quantified
by colony counts in feces. On day 7, mice were sacrificed and
IL-17a producing cells were identified in MLNs following 4.5 h
restimulationwith 1×Cell stimulation cocktail as described above.
Statistical analysis
Results are presented as means ±1 SD unless otherwise stated
and groups were compared using a Student’s t-test, or for multiple
groups, a one-way ANOVA followed by a Bonferroni posttest using
Prism Software (GraphPad Software, Inc.).
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